fda category 2 bulk drug substances list bpc-157 An advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with BPC-157 PASSED! Gabriel Alizaidy, MD,
BPC 157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote. It does not immediately make fda category 2 bulk drug substances list bpc 157 Industry Update: Interim 503A and 503B Bulks BPC 157 Oral vs Injection: Benefits, Bioavailability & Recovery FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies FDA Moves to Reevaluate Several Peptides American Med Spa Association Is BPC 157 Legal in 2026? FDA Compounding Status Explained
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




